Tanaceti parthenii herba
This is a summary of the scientific conclusions reached by the Committee on Herbal Medicinal Products (HMPC) on the medicinal uses of feverfew herb. The HMPC conclusions are taken into account by EU Member States when evaluating applications for the licensing of herbal medicines containing feverfew herb.
This summary is not intended to provide practical advice on how to use medicines containing feverfew herb. For practical information about using feverfew herb medicines, patients should read the package leaflet that comes with the medicine or contact their doctor or pharmacist.
|Latin name||Tanaceti parthenii herba|
|English common name||Feverfew|
|Botanical name||Tanacetum parthenium (L.) Schultz Bip.|
Pain and inflammation
F: Assessment finalised
|Date added to the inventory||
|Date added to priority list||
|Outcome of European assessment||
European Union herbal monograph